Cytek Biosciences, Inc. (CTKB) vs QuidelOrtho Corporation (QDEL)

Cytek Biosciences, Inc. and QuidelOrtho Corporation are both Medical Devices companies. QuidelOrtho Corporation is the larger, with a market value of $880.5M against $701.9M — 1.3× the size. Cytek Biosciences, Inc. grew revenue faster over the last twelve months: 5.50% against −4.47%. QuidelOrtho Corporation has the higher net margin (−14.2% vs −39.1%) and the higher return on invested capital (−1.75% vs −42.1%). Across the 18 metrics below, QuidelOrtho Corporation leads on 10 and Cytek Biosciences, Inc. on 8.

Valuation

Metric CTKB QDEL Medical Devices median
P/E n/m n/m 24.94
P/S 3.65 0.28 2.66
P/B 2.36 0.41 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA n/m 10.27 11.42
EV/Sales 2.42 1.35 2.76
Earnings yield (10.77%) (50.45%) (12.66%)
Free cash flow yield (1.76%) (15.82%) (7.18%)

Profitability

Metric CTKB QDEL Medical Devices median
Gross margin 54.75% 44.22% 57.76%
Operating margin (21.13%) (4.91%) (14.84%)
Net margin (39.10%) (14.24%) (14.45%)
Free cash flow margin (6.43%) (4.48%) (5.70%)
Return on equity (23.20%) (19.29%) (10.56%)
Return on assets (17.26%) (6.45%) (17.26%)
Return on invested capital (42.08%) (1.75%) (5.22%)

Growth

Metric CTKB QDEL Medical Devices median
Revenue growth (TTM) 5.50% (4.47%) 10.41%
EPS growth (last fiscal year) (940.00%) 44.66% 28.17%
Revenue growth, 5-year CAGR 16.76% 10.44% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTKB QDEL Medical Devices median
Debt to equity 0.00 1.64 0.04
Current ratio 4.46 1.36 2.67
Net debt to EBITDA 9.19 11.10 0.54

Dividend

Metric CTKB QDEL Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric CTKB QDEL Medical Devices median
Market cap 701.91m 880.51m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack